ASGCT Late Breakers: Pfizer’s Duchenne Results Underwhelm As Next-Gen Approaches Emerge

Sarepta Set For Landmark Approval

 
• By Andrew McConaghie
  
LA Convention Center
An aerlal view of the L.A. Convenstion Center, the venue for this year's ASGCT annual congress. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D